| Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version … I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ... European journal of nuclear medicine and molecular imaging 46, 540-557, 2019 | 497 | 2019 |
| High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors J Brummelman, EMC Mazza, G Alvisi, FS Colombo, A Grilli, J Mikulak, ... Journal of Experimental Medicine 215 (10), 2520-2535, 2018 | 338 | 2018 |
| PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence E Lopci, I Grassi, A Chiti, C Nanni, G Cicoria, L Toschi, C Fonti, F Lodi, ... American journal of nuclear medicine and molecular imaging 4 (4), 365, 2014 | 261 | 2014 |
| FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature N Aide, RJ Hicks, C Le Tourneau, S Lheureux, S Fanti, E Lopci European journal of nuclear medicine and molecular imaging 46, 238-250, 2019 | 244 | 2019 |
| Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review AM Maffione, E Lopci, C Bluemel, F Giammarile, K Herrmann, D Rubello European journal of nuclear medicine and molecular imaging 42, 152-163, 2015 | 172 | 2015 |
| IRF4 instructs effector Treg differentiation and immune suppression in human cancer G Alvisi, J Brummelman, S Puccio, EMC Mazza, EP Tomada, A Losurdo, ... The Journal of clinical investigation 130 (6), 3137-3150, 2020 | 147 | 2020 |
| Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery E Lopci, L Toschi, F Grizzi, D Rahal, L Olivari, GF Castino, S Marchetti, ... European journal of nuclear medicine and molecular imaging 43, 1954-1961, 2016 | 146 | 2016 |
| Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study A Piccardo, E Lopci, M Conte, A Garaventa, L Foppiani, V Altrinetti, ... European journal of nuclear medicine and molecular imaging 39, 57-71, 2012 | 137 | 2012 |
| Guidelines on nuclear medicine imaging in neuroblastoma Z Bar-Sever, L Biassoni, B Shulkin, G Kong, MS Hofman, E Lopci, I Manea, ... European journal of nuclear medicine and molecular imaging 45, 2009-2024, 2018 | 135 | 2018 |
| Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC … FE Lecouvet, DE Oprea-Lager, Y Liu, P Ost, L Bidaut, L Collette, ... The Lancet Oncology 19 (10), e534-e545, 2018 | 121 | 2018 |
| 68Ga-PSMA positron emission tomography/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic … E Lopci, A Saita, M Lazzeri, G Lughezzani, P Colombo, NM Buffi, R Hurle, ... The Journal of Urology 200 (1), 95-103, 2018 | 107 | 2018 |
| Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma E Lopci, M Riva, L Olivari, F Raneri, R Soffietti, A Piccardo, A Bizzi, ... European journal of nuclear medicine and molecular imaging 44, 1155-1164, 2017 | 86 | 2017 |
| Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven … L Fournier, L Costaridou, L Bidaut, N Michoux, FE Lecouvet, ... European radiology 31, 6001-6012, 2021 | 84 | 2021 |
| Hyperprogressive disease in patients with non–small cell lung cancer treated with checkpoint inhibitors: the role of 18F-FDG PET/CT A Castello, S Rossi, E Mazziotti, L Toschi, E Lopci Journal of Nuclear Medicine 61 (6), 821-826, 2020 | 82 | 2020 |
| 64CuCl2 PET/CT in prostate cancer relapse A Piccardo, F Paparo, M Puntoni, S Righi, G Bottoni, L Bacigalupo, ... Journal of Nuclear Medicine 59 (3), 444-451, 2018 | 76 | 2018 |
| Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in … E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, ... European journal of nuclear medicine and molecular imaging 49 (7), 2323-2341, 2022 | 75 | 2022 |
| MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients E Derenzini, MP Fina, V Stefoni, C Pellegrini, F Venturini, A Broccoli, ... Annals of oncology 21 (6), 1173-1178, 2010 | 74 | 2010 |
| The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma N Quartuccio, G Treglia, M Salsano, MV Mattoli, B Muoio, A Piccardo, ... Radiology and Oncology 47 (2), 97-183, 2013 | 72 | 2013 |
| 18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR E Lopci, A Piccardo, C Nanni, V Altrinetti, A Garaventa, A Pession, ... Clinical nuclear medicine 37 (4), e73-e78, 2012 | 70 | 2012 |
| Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review F Alongi, B De Bari, F Campostrini, S Arcangeli, DV Matei, E Lopci, ... Critical reviews in oncology/hematology 88 (3), 550-563, 2013 | 67 | 2013 |